Analysis of Subgroup Differences in the ION-3 Trial of Ledipasvir-Sofosbuvir in Chronic Hepatitis C Infection

Lignende værker

• Reply: Subgroup Differences in Response to 8 Weeks of Ledipasvir/Sofosbuvir for Chronic Hepatitis C
  af: O’Brien, Thomas R., et al.
  Udgivet: (2015)
• Subgroup Differences in Response to 8 Weeks of Ledipasvir/Sofosbuvir for Chronic Hepatitis C
  af: O'Brien, Thomas R., et al.
  Udgivet: (2014)
• Role of ledipasvir/sofosbuvir combination for genotype 1 hepatitis C virus infection
  af: Sundaram, Vinay, et al.
  Udgivet: (2016)
• Blistering Disease During the Treatment of Chronic Hepatitis C With Ledipasvir/Sofosbuvir
  af: Cash, Joshua, et al.
  Udgivet: (2019)
• Decreasing racial disparity with the combination of ledipasvir–sofosbuvir for the treatment of chronic hepatitis C
  af: Naylor, Paul H, et al.
  Udgivet: (2017)